Ranbaxy Voluntary Recalls Atorvastatin Calcium TabletsBy
Ranbaxy Inc. has initiated a nationwide voluntary Class II recall of atorvastatin calcium tablets, 10 mg, 90-count tablets per bottle, prescription only, based on a product complaint was received by a pharmacist who discovered an atorvastatin 20-mg tablet inside a sealed bottle of 90-count atorvastatin 10 mg, according to FDA’s March 5, 2014 enforcement report. A Class II recall is where a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote, according to FDA. The recall of the anticholesterol drug applies to 64,626 bottles of atorvastatin. The recall was initiated on January 16, 2014.